PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
CMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy.
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2011-06-01
|
Series: | Vestnik Transplantologii i Iskusstvennyh Organov |
Subjects: | |
Online Access: | https://journal.transpl.ru/vtio/article/view/411 |
_version_ | 1797872088835424256 |
---|---|
author | V. V. Ryazhenov S. G. Gorokhova |
author_facet | V. V. Ryazhenov S. G. Gorokhova |
author_sort | V. V. Ryazhenov |
collection | DOAJ |
description | CMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy. |
first_indexed | 2024-04-10T00:53:16Z |
format | Article |
id | doaj.art-aa02b547067446aa921e2e6d942db6ae |
institution | Directory Open Access Journal |
issn | 1995-1191 |
language | Russian |
last_indexed | 2024-04-10T00:53:16Z |
publishDate | 2011-06-01 |
publisher | Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov |
record_format | Article |
series | Vestnik Transplantologii i Iskusstvennyh Organov |
spelling | doaj.art-aa02b547067446aa921e2e6d942db6ae2023-03-13T10:37:21ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovVestnik Transplantologii i Iskusstvennyh Organov1995-11912011-06-01133202510.15825/1995-1191-2011-3-20-25354PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTSV. V. Ryazhenov0S. G. Gorokhova1I.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityCMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy.https://journal.transpl.ru/vtio/article/view/411kidney transplantationcmv infectionbudget impact analysiseconomic rational indicator of previous periods cost. |
spellingShingle | V. V. Ryazhenov S. G. Gorokhova PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS Vestnik Transplantologii i Iskusstvennyh Organov kidney transplantation cmv infection budget impact analysis economic rational indicator of previous periods cost. |
title | PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS |
title_full | PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS |
title_fullStr | PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS |
title_full_unstemmed | PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS |
title_short | PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS |
title_sort | pharmacoeconomic benefits of cytomegalovirus infection prophylactic strategy for renal transplant recipients |
topic | kidney transplantation cmv infection budget impact analysis economic rational indicator of previous periods cost. |
url | https://journal.transpl.ru/vtio/article/view/411 |
work_keys_str_mv | AT vvryazhenov pharmacoeconomicbenefitsofcytomegalovirusinfectionprophylacticstrategyforrenaltransplantrecipients AT sggorokhova pharmacoeconomicbenefitsofcytomegalovirusinfectionprophylacticstrategyforrenaltransplantrecipients |